Amanda is a partner based in our Oxford office. She works with many start-up companies in the Oxford area and beyond to assist them in developing their IP. Amanda’s work focuses on the pharmaceutical and medtech sectors, including anti-microbials, re-purposed drugs, pharmaceutical formulations, medical sensors and other medical equipment, but she also has experience in a broad range of chemical technologies including sugar chemistry and alloys.
Amanda is known for her pragmatic approach to IP strategy and portfolio management. She is recommended by The Legal 500. She is also ranked as an IP Star by Managing Intellectual Property, with clients commenting that Amanda “understands our needs and finds practical and strategic solutions to problems”. She is very experienced in assisting clients in freedom to operate investigations and due diligence projects. Amanda advises both those looking to invest in a new technology and those seeking investment.
In addition to her local client base, Amanda has many clients in China and visits China at least once a year, keeping her fully up-to-date with legal developments.
A further focus of Amanda’s work is representing clients at opposition before the European Patent Office, where she has acted in a number of high profile opposition cases. Amanda's experience extends to the defence of several pharmaceutical patents including those for sofosbuvir, Mozobil and eculizumab. She also has extensive experience in handling oppositions in blood coagulation therapies, dialysis, wound healing devices and materials.
Amanda joined J A Kemp in 1998 and became a partner in 2008.
University of Oxford, Masters Degree in Chemistry including options in biological chemistry and research in nitrogen heterocyclic preparative chemistry
European Patent Attorney; UK Chartered Patent Attorney
Fellow of the Chartered Institute of Patent Attorneys (CIPA); Member of the Institute of Professional Representatives before the European Patent Office (EPI)